Best Peptides for Joint Pain & Repair
Peptides researched for joint health, cartilage repair, arthritis relief, and connective tissue support.
Understanding Joint Pain Peptides
Joint pain peptides target the underlying causes of joint deterioration rather than just masking symptoms. BPC-157 has shown protective effects on cartilage and tendon-to-bone healing in animal models. TB-500 promotes cell migration essential for tissue repair. GHK-Cu supports connective tissue remodeling. Growth hormone peptides may indirectly support joint health through improved collagen synthesis and tissue regeneration. These compounds are increasingly researched as alternatives or complements to traditional joint treatments.
Key Considerations
- BPC-157 injected near the affected joint may provide localized benefits
- Combining BPC-157 with TB-500 is a common protocol for joint issues
- GH secretagogues may support joint health through improved collagen production
- Physical therapy and proper movement remain essential
- Severe joint damage may require medical intervention beyond peptides
FDA Approved Options (1)
Research Peptides (6)
These peptides are being researched but are not FDA approved. They should only be considered for research purposes or under medical supervision.
BPC-157
PreclinicalBPC-157 is a synthetic 15-amino-acid peptide (sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) based on a fragment of a protective protein found in human gastric juice. It is studied almost entirely in animals for tendon, ligament, gut, and tissue healing, and it has racked up hundreds of preclinical papers. The catch: it is not approved by any regulator for any use, and the human evidence is a handful of small pilot studies, not real clinical proof.
TB-500
PreclinicalTB-500 is a synthetic peptide that copies the active region of thymosin beta-4, a natural protein that controls how cells build and move their internal skeleton. Most TB-500 products reproduce the short LKKTETQ sequence (residues 17 to 23) responsible for binding actin and driving cell migration, which is why it gets marketed for tendon, muscle, and wound repair. Here is the honest part: there are essentially no completed human trials of the TB-500 fragment itself, and almost all the human clinical data is for the full-length thymosin beta-4 molecule, which is related but not the same thing.
Wolverine Stack
PreclinicalThe Wolverine Stack is not a single drug. It is a popular nickname for combining two regenerative peptides, BPC-157 and TB-500 (a synthetic fragment of thymosin beta-4), usually injected together for injury recovery, tendon and soft-tissue repair, and inflammation. Neither peptide is FDA-approved for human use, and the combination itself has never been tested in a human clinical trial. Almost all supporting data is from animal studies on the individual peptides.
Pentadecapeptide
PreclinicalPentadecapeptide almost always means BPC-157, a synthetic 15-amino-acid chain (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a protein found in human gastric juice. It is one of the most hyped 'healing' peptides online, marketed for tendon, gut, and muscle repair, but here is the catch: essentially all of the supporting evidence is from rats and mice. There is no FDA approval and no completed human clinical trial proving it does any of this.
Cartalax
PreclinicalCartalax is a synthetic tripeptide (Ala-Glu-Asp, or AED) from the Khavinson family of short peptide bioregulators, studied as a cartilage and connective-tissue regulator. It is a research compound, not an approved drug, and no registered human clinical trials exist.
Thymosin Beta-4
Clinical TrialsThymosin beta-4 (Tbeta4) is a small 43 amino acid peptide found in nearly every cell in the body, originally isolated from the thymus. Its main job is binding and sequestering G-actin, the building block of the cell's internal scaffolding, which lets it influence cell movement, wound repair, and tissue regeneration. It is researched heavily for healing of skin, cornea, and heart tissue, but it is not an FDA-approved drug. (The injectable sold as TB-500 is a synthetic fragment marketed as related to Tbeta4, not the full natural peptide.)
Frequently Asked Questions
What is the best peptide for joint pain?
BPC-157 is the most commonly researched peptide for joint issues, with animal studies showing cartilage protection, reduced inflammation, and accelerated tendon-to-bone healing. TB-500 complements it by promoting cell migration for tissue repair.
Can peptides repair cartilage?
Preclinical research suggests BPC-157 has chondroprotective effects (protects cartilage) and may support cartilage repair. However, severe cartilage loss (bone-on-bone) is unlikely to be fully reversed by any peptide alone.
How do I use BPC-157 for joint pain?
Community protocols typically involve subcutaneous injection near the affected joint at 250-500 mcg, 1-2 times daily, for 4-8 weeks. Some protocols combine it with TB-500. This is anecdotal - no human trials exist for this specific application.
Explore Other Goals
Compare Peptides Side-by-Side
Use our comparison tool to evaluate multiple peptides at once.
Peptide Reconstitution Calculator
Calculate exact dilution volumes, syringe units, and doses per vial for any peptide.
Get Weekly Peptide Research Updates
New peptides, studies, and FDA changes delivered to your inbox.